Table of Contents
SFA Intervention: The Next Level
Considerations on tomorrow's effectiveness benchmarks.
The ISR Treatment Paradigm
Defining the best way to approach femoropopliteal
Sponsored by Spectranetics Corporation
In This Issue
Chief Medical Editors' Page
Ask the Experts: What SFA Trials Would You Most Like to See?
Experts discuss key questions to answer, potential trial designs, and the likelihood that the trials will be undertaken.
With Peter A. Schneider, MD; Thomas Zeller, MD; Osamu Iida, MD; Marianne Brodmann, MD; Krishna Rocha-Singh, MD; and Christopher Metzger, MD
Medical Affairs Corner
Sponsored by Medtronic
Sponsored by Cardiovascular Systems, Inc.
Promising New 30-Day Data for Lower Extremity Endovascular Treatment
Discussion and roundtable interview of the LIBERTY 360° study of 1,204 Rutherford class 2 to 6 patients, including 100 Rutherford class 6 patients.
By George L. Adams, MD, MHS; Gary M. Ansel, MD; William A. Gray, MD; and J.A. Mustapha, MD
October 2016 Supplement